Albumin‐bilirubin score is superior to platelet‐albumin‐bilirubin score and model for end‐state liver disease sodium for predicting posthepatectomy liver failure

Risk stratification for patients undergoing hepatectomy can be attempted using established models. This study compares the platelet‐albumin‐bilirubin (PALBI) score with albumin‐bilirubin (ALBI) and model for end‐stage liver disease sodium (MELD‐Na) for predicting posthepatectomy liver failure (PHLF) and 30‐day mortality.

[1]  R. Freeman,et al.  From Child-Pugh to MELD score and beyond: taking a walk down memory lane. , 2021, Annals of hepatology.

[2]  J. Hodson,et al.  Role of liver support systems in the management of post hepatectomy liver failure: A systematic review of the literature , 2021, Annals of hepato-biliary-pancreatic surgery.

[3]  Kaijun Huang,et al.  Development and Validation of a Nomogram Based on Noninvasive Liver Reserve and Fibrosis (PALBI and FIB-4) Model to Predict Posthepatectomy Liver Failure Grade B-C in Patients with Hepatocellular Carcinoma , 2021, Journal of oncology.

[4]  H. Pitt,et al.  Predicting Outcomes of Surgery in Patients with Liver Disease: Albumin-Bilirubin Score vs Model for End-stage Liver Disease-Sodium Score. , 2020, Journal of the American College of Surgeons.

[5]  Q. Pang,et al.  The Significance of Platelet–Albumin–Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count , 2020, Cancer management and research.

[6]  N. Gusani,et al.  The Future Liver Remnant , 2020, The American surgeon.

[7]  R. Dong,et al.  An Improved Scoring System Based on Platelet-Albumin-Bilirubin in Predicting Posthepatectomy Liver Failure Outcomes , 2020, Digestive Diseases.

[8]  Shuqun Cheng,et al.  Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study , 2020, BMC Cancer.

[9]  H. Pitt,et al.  Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy Outcomes. , 2020, Journal of the American College of Surgeons.

[10]  Wei Wei,et al.  Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[11]  Andrea Tsoris,et al.  Use Of The Child Pugh Score In Liver Disease , 2019 .

[12]  Myeong Jun Song,et al.  Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study , 2019, PloS one.

[13]  Shengping Yang,et al.  The receiver operating characteristic (ROC) curve , 2017 .

[14]  Chia-Yang Hsu,et al.  ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era , 2017, Journal of gastroenterology and hepatology.

[15]  H. Pitt,et al.  Albumin-Bilirubin Score: Predicting Short-Term Outcomes Including Bile Leak and Post-hepatectomy Liver Failure Following Hepatic Resection , 2017, Journal of Gastrointestinal Surgery.

[16]  A. Zhu,et al.  Comparison of hepatocellular carcinoma in Eastern versus Western populations , 2016, Cancer.

[17]  C. Hollenbeak,et al.  Portal Hypertension: An Underestimated Entity? , 2016, Annals of surgery.

[18]  H. Eguchi,et al.  Platelet count is more useful for predicting posthepatectomy liver failure at surgery for hepatocellular carcinoma than indocyanine green clearance test , 2016, Journal of surgical oncology.

[19]  Q. Pang,et al.  The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma , 2015, Medicine.

[20]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Bruix,et al.  Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis , 2015, Hepatology.

[22]  Y. Fong,et al.  Post-hepatectomy liver failure. , 2014, Hepatobiliary surgery and nutrition.

[23]  N. Ohkohchi,et al.  Effects of thrombopoietin on growth of hepatocellular carcinoma: Is thrombopoietin therapy for liver disease safe or not? , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[24]  J. Shindoh,et al.  Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases , 2013, Annals of Surgical Oncology.

[25]  Jürgen Weitz,et al.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). , 2011, Surgery.

[26]  Steven A Curley,et al.  Three Hundred and One Consecutive Extended Right Hepatectomies: Evaluation of Outcome Based on Systematic Liver Volumetry , 2009, Annals of surgery.

[27]  G. Jung,et al.  Model for end-stage liver disease , 2008, Der Chirurg.

[28]  H. Petrowsky,et al.  Strategies for safer liver surgery and partial liver transplantation. , 2007, The New England journal of medicine.

[29]  W. Kim,et al.  The model for end‐stage liver disease (MELD) , 2007, Hepatology.

[30]  W. Henderson,et al.  Predictive Indices of Morbidity and Mortality After Liver Resection , 2006, Annals of surgery.

[31]  R. Adams,et al.  Model for End-Stage Liver Disease (MELD) Predicts Nontransplant Surgical Mortality in Patients With Cirrhosis , 2005, Annals of surgery.

[32]  Roland Materne,et al.  Body surface area and body weight predict total liver volume in Western adults , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[33]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[34]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.

[35]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.

[36]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.